SS-31 reconstitution calculator
- Concentration
- 5 mg/mL
- Doses per vial
- 10
- Weeks (1 dose/wk)
- 10
20 units (0.2 mL) on a 1 mL U-100 syringe: 1 mg from a 10 mg vial + 2 mL water (SS-31).
Dosing table for a 10 mg vial
Syringe units (U-100) for each dose, by how much bacteriostatic water you add.
| Dose | 1 mL water | 2 mL water | 2.5 mL water | 3 mL water |
|---|---|---|---|---|
| 0.5 mg | 5 | 10 | 12.5 | 15 |
| 1 mg | 10 | 20 | 25 | 30 |
| 2 mg | 20 | 40 | 50 | 60 |
| 5 mg | 50 | 100 | 125 | 150 |
| 10 mg | 100 | 200 | 250 | 300 |
How the math works
Concentration is the vial's milligrams divided by the water you add. Volume to draw is your dose divided by that concentration. On a U-100 syringe, 1 mL is 100 units, so units = mL × 100.
1 mg ÷ 5 mg/mL = 0.2 mL
0.2 mL × 100 = 20 units
How many units is 1 mg of SS-31?
With a 10 mg vial and 2 mL of bacteriostatic water, 1 mg is 20 units (0.20 mL) on a U-100 syringe. With 1 mL of water it is 10 units. The answer always depends on how much water was added.
How much bacteriostatic water for a 10 mg SS-31 vial?
The water only sets the concentration; the amount of SS-31 in the vial stays the same. 2 mL makes 5 mg/mL, so 1 mg is 20 units. 2.5 mL makes 4 mg/mL, so the same 1 mg is 25 units. More water makes small doses easier to measure but needs more volume per injection.
How many 1 mg doses are in a 10 mg vial?
10 ÷ 1 = 10, so 10 full doses of 1 mg. Any liquid lost in the needle and vial is not counted.
SS-31 50mg: how many doses is that vial?
At the labelled daily amount of 40 mg a 50 mg vial holds 1.25 doses; at 20 mg it holds 2.5.
Calculated from vial mg 50; doses mg 40, 20. Formula: 50/40 = 1.25; 50/20 = 2.5
How to reconstitute SS-31?
The approved product is already a solution and needs no mixing; the label describes it as a single-patient-use vial.[3]
SS-31 10mg reconstitution: what does 2 mL give?
A 10 mg vial in 2 mL is 5 mg/mL and each unit is 0.05 mg, so a unit reading is 16 times smaller than the 0.8 mg per unit of the labelled 80 mg/mL product.
Calculated from vial mg 10; water m L 2; label mg per m L 80. Formula: 10/2 = 5 mg/mL x 0.01 = 0.05 mg; 80 x 0.01 = 0.8 mg; 0.8/0.05 = 16
Preset doses are round numbers for the arithmetic, not dosing guidance. Vial sizes are the ones most often mentioned for SS-31 in community discussions.
The approved product is a premixed 80 mg/mL vial
Forzinity, the labelled elamipretide product, comes as a 280 mg/3.5 mL solution at 80 mg/mL in single-patient-use vials, so nothing is reconstituted.[3]
The labelled dose for patients weighing at least 30 kg is 40 mg subcutaneously once daily.[3]
The label says to discard vials 8 days after first opening.[3]
At the labelled 80 mg/mL, 40 mg is 0.5 mL, which is 50 units on a U-100 syringe. A 280 mg vial holds 7 doses of 40 mg (280/40), which fits within the 8-day discard window.
Calculated from dose mg 40; label mg per m L 80; vial mg 280. Formula: 40/80 = 0.5 mL = 50 units; 280/40 = 7 doses
For adults with severe renal impairment not on dialysis, the label halves the daily dose.[3]
The 10, 25 and 50 mg research sizes against the 40 mg dose
A 40 mg amount is 4 times the 10 mg vial and 1.6 times the 25 mg vial, so neither can supply one. A 50 mg vial mixed with 1 mL is 50 mg/mL and a 40 mg amount reads 80 units; with 2 mL it is 25 mg/mL and the same amount reads 160 units, more than a 1 mL syringe holds.
Calculated from dose mg 40; vials mg 10, 25, 50; water m L 1, 2. Formula: 40/10 = 4; 40/25 = 1.6; 40/50x100 = 80; 40/25x100 = 160 units
A 50 mg vial then holds 1.25 doses of 40 mg (50/40), so a second dose is not available from the same vial.
Calculated from vial mg 50; dose mg 40. Formula: 50/40 = 1.25
In a research vial, the 20 mg dose in the label's severe-renal-impairment row would read 40 units from a 50 mg vial in 1 mL, against the 0.25 mL (25 units) the labelled 80 mg/mL solution gives.
Calculated from dose mg 20; vial mg 50; water m L 1; label mg per m L 80. Formula: 20/50x100 = 40 units; 20/80 = 0.25 mL = 25 units
Trial amounts
The Barth syndrome crossover trial gave 40 mg per day of elamipretide or placebo for 12 weeks per period.[4]
A dose-escalation trial used 2-hour intravenous infusions in mg/kg/h rather than daily injections.[5]
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3FORZINITY prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 4A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism.Genetics in medicine : official journal of the American College of Medical Genetics · 2021PMID 33077895Accessed 2 Oct 2026
- 5Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy.Neurology · 2018PMID 29500292Accessed 2 Oct 2026
Found an error? Report a correction.